The plant family Amaryllidaceae is known for its horticultural and ornamental appeal as well as its medicinal value. In relation to these characteristics, trade in Amaryllid flower varieties (especially daffodils) is a multi-million dollar revenue generator for the floriculture industry. Of greater significance are the medicinal attributes of the family, which has already spawned the Alzheimer's prescription drug galanthamine, a potent and selective inhibitor of the enzyme acetylcholinesterase, of significance in the progression of neurodegeneration associated with motor neuron diseases, with annual global sales of around $150 million. Furthermore, it is anticipated that an anticancer drug target related to the Amaryllidaceae alkaloid pancratistatin, presently under advanced clinical evaluation, will enter commercial circulation within the next decade. Members of the Amaryllidaceae are distributed through both tropical and subtropical regions of the globe, but are of prominence within three distinct geographical locations, including Andean South America, the Mediterranean basin, and southern Africa. The southern African zone is known to harbor at least a third of the worldwide complement of around 1000 species, many of which are widely utilized in the traditional medicinal practices of the indigenous people of the region. Given its therapeutic and economic value, its natural abundance in the southern African region, coupled to its widespread usage in ethnic medicine, the family Amaryllidaceae provides a diverse and accessible platform for phytochemical based drug discovery. A consolidation of its traditional usage as well as its chemical and pharmacological profiles will thus guide efforts aimed at maximizing this potential. In undertaking this survey of the Amaryllidaceae of southern African, we aimed to achieve these goals.
The Amaryllidaceae J. St.-Hil. is a large family of perennial, herbaceous and bulbous flowering plants with roughly 1000 species in 60 genera [1] . Commonly referred to as "Amaryllids", they include popular ornamental varieties such as daffodils (Narcissus), snowdrops (Galanthus) and snowflakes (Leucojum) [2] . Their commercial value is thus significant to the floriculture industry, which sees annual sales of over 20 million cut daffodils from the Puyallup River Valley of Washington State alone [3a] . In popular culture, on annual "Daffodil days" (31 st March to 3 rd April) over $3 million in daffodil sales is raised in Ontario (Canada) alone for cancer awareness [3b] . Although pantropical in distribution, members of the family are of particular provenance in Andean South America, the Mediterranean, and southern Africa [1] . Ethnic usage of Narcissus in the Mediterranean can be dated to the times of Hippocrates and Pliny [4a] , while archeological finds at Inca ruins in South America have shown floral depictions of Ismene, Pyolirion and Stenomesson on ceremonial drinking vessels [4b] . In southern Africa, San rock paintings of Brunsvigia species in the Lesotho highlands attest to the usage of the Amaryllidaceae by the region's first inhabitants [4c] . The Amaryllidaceae occurring in southern Africa belong almost exclusively to the tribes Amaryllideae, Haemantheae and Cyrtantheae, which are three of fourteen recognized tribes in this family [1,5a] . Amaryllideae J. St.-Hil. is a monophyletic group consisting of eleven currently recognized genera and approximately 155 species [5b,c] . Members of the tribe, typified by Crinum, inhabit grassland, savanna and tropical forests in sub-Saharan Africa, but are most speciose in southern Africa where habitats include semi-arid dwarf shrublands in the winter rainfall region. By contrast, the tribe Haemantheae Pax (Hutchinson) consists of five genera (Scadoxus, Haemanthus, Clivia, Gethyllis and Apodolirion), which are distributed through the various regions in southern Africa [5d,e]. Of the African clades, Cyrtantheae Salisb. is recognized as a tribe unto itself consisting of a single endemic genus, Cyrtanthus [1,5a] . This tribe is the only African taxon with flat, winged phytomelanous seeds characteristic of many American genera of the Amaryllidaceae [5f-h]. Also, it is the most diverse in floral morphology of any genus in this plant family [5f-h]. Of any location worldwide, the winter rainfall area of the Western Cape in South Africa, which is part of the broader Capensis floral kingdom, is most speciose in Amaryllid varieties [1] , many of which may be seen in bloom during spring in the Namaqualand region amongst the spectacular variety and profusion of wild flowers. A display of the esthetic floral characteristics of some of the species covered in this review is shown in Figure 1 [6] . Chemically, the Amaryllidaceae is widely known for its unique alkaloidal constituents [7a-c] . Galanthamine (1) , lycorine (2) and crinine (3) are representative of the three major structural-types for these alkaloids (Scheme 1), while homolycorine (4), tazettine (5) and montanine (6) make up the minor series of alkaloids discernible within the Amaryllidaceae [7a-c] . Other less-conspicuous members include degraded, oxidized and truncated variants such as trisphaeridine (7) and ismine (8). All of these structurally-diverse chemical entities are related as a consequence of their biogenesis from a common precursor norbelladine (9) [7a-c] . Of these alkaloids, galanthamine (1) has garnered the most attention in both the secular and scientific media after its commercialization as a prescription drug in the treatment of Alzheimer's disease [8a-c] . This biologically-privileged status was drawn out of its potent, selective and reversible inhibitory interaction with the enzyme acetylcholineserase (AChE), of significance in the progression of neurodegeneration associated with the pathophysiology of Alzheimer's disease [8a-c,9a,b] . Interestingly, the discovery of this drug evolved out of the traditional usage of Galanthus species, from which galanthamine was first isolated, in the Caucasus region of Eastern Europe [8a-c]. known for their potent and cell line-specific anticancer activities, and are presently at various stages of development, with a clinical candidate earmarked for commercialization within the next decade [10] . Mechanistically, these phenanthridones are known to initiate cell death via the apoptotic pathway, as indicated by early activation of caspase-3 followed by flipping of phosphatidyl serine, selectively in mitochondria of cancer cells with minimal effect on normal cells [11] .
Given these promising biological properties, accompanied by their synthetically-challenging molecular structures, as well as their limited availability from natural sources, these alkaloids have served to fuel sustained efforts in order to deliver a potent, selective and readily bioavailable drug target with facile synthetic access [12] . Furthermore, a stronger case could be made for development of these alkaloids into commercially viable entities by the low interaction of pancratistatin (10) with the cytochrome P450 3A4 isoenzyme, which accounts for the majority of drugs metabolized in humans [13] . In addition, structure-activity relationship (SAR) studies invoking these potential drug targets have collectively facilitated the elucidation of elements of the apoptosis-inducing pharmacophore innate to these molecules [14] .
Given these interesting botanical, chemical and pharmacological attributes of the Amaryllidaceae, as well as their natural abundance in the southern African area, a consolidation of these properties in a single platform should facilitate investigations in the important area of drug discovery. In covering developments in the field from 1998 to 2012, this review builds on a previous survey of the family up to 1997 [15] . The three main areas of focus in this study of the South African Amaryllidaceae are: 1) ethnopharmacological usage; 2) alkaloid composition; and 3) biological activity.
Overall, the survey revealed that during this period, 26 different species representing 9 genera of all three tribes of the South African Amaryllidaceae were examined phytochemically, leading to the identification of a total of 83 alkaloids (Table 1 ). In context, this is a sizeable number of structures, as the previous survey accounted for the presence of 110 alkaloids for all years leading up to 1997 [15] . Furthermore, this number was dividable into the different groups of compounds characteristic of the Amaryllidaceae, including 21 crinanes, 23 -crinanes, 15 lycoranes, 2 galanthamine compounds, 8 tazettine representatives, 5 homolycorine compounds, 4 montanine analogues, and 5 miscellaneous alkaloids. Although the crinane alkaloids were the most populous, lycorine 2 was the most common compound, having been isolated on ten separate occasions. 
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Scheme 1:
Structurally diverse alkaloid representatives of the Amaryllidaceae derived from the common biosynthetic precursor norbelladine 9.
The study also reflected that the majority of species examined have uses in the traditional medicinal practice systems of the indigenous peoples of South Africa. Furthermore, biological evaluation of single compound isolates have led to the identification of several targets as leads with significant potential for clinical development, notably in the areas of cancer and Alzheimer's chemotherapy. Not long after the first review of the South African Amaryllidaceae [15] , Brunsvigia littoralis was examined in 1998 for its alkaloid constituents as well as cytotoxic and antimalarial effects [18] . In the study, four compounds lycorine (2), crinine (3), ambelline (38) and 1,2-di-O-acetyllycorine (61) were identified and, together with the synthesized analogues 3-O-acetylcrinine and 11-O-acetylambelline, screened for cytotoxic and antimalarial effects. Of these, only lycorine and 1,2-di-O-acetyllycorine were significantly active against BL6 mouse melanoma cells (IC 50 s of 1.8 and 8.9 g/mL, respectively), with all other compounds exhibiting IC 50 s > 100 g/mL [18] . Against the chloroquine-sensitive D10 strain of the malarial pathogen Plasmodium falciparum, lycorine (2) and its diacetyl analogue (61) were the most active with IC 50 s of 0.62 g/mL (SI 2.90) and 1.0 g/mL (SI 8.9), respectively. Against the chloroquine-resistant FAC8 strain, both of these compounds were also the most potent (IC 50 s of 0.7 g/mL (SI 2.57) and 1.0 g/mL (SI 8.9), respectively), all other compounds exhibiting IC 50 s > 20 g/mL against both plasmodial strains [18] . The only other work in 1998 on the South African Amaryllidaceae involved the isolation and identification of the cytotoxic alkaloid constituents of Crinum delagoense, a plant known to be used in the traditional treatment of cancer [19] . In the process, six alkaloids representing three groups of the Amaryllidaceae were elucidated as lycorine (2), 6hydroxycrinamine (14), hamayne (15) , delagoensine (18), delagoenine (19) and criwelline (83) based on both physical and spectroscopic data, of which only lycorine and 6-hydroxycrinamine were markedly active against the BL6 mouse melanoma cell line, thus substantiating the traditional usage of the plant [19] . Furthermore, this work is significant in uncovering in delagoensine (18) and delagoenine (19) , the first C-12 substituted crinane analogues of the Amaryllidaceae. Interestingly, within the crinane series, hydroxy substitutions  to the nitrogen atom have previously been found only at C-4a and C-6 [7, 15] . A single reference to the Amaryllidaceae of southern Africa was found for the year 1999, in this case pertaining to the phytochemical investigation of Crinum bulbispermum [20] , in which seven alkaloids were identified, including the known compounds crinamine (11), 6hydroxycrinamine (14), 3-O-acetylhamayne (16) and bulbispermine (25) , as well as the novel N-desmethyl-8-ethoxypretazettine (81), N-desmethyl-8-ethoxypretazettine (82) and 8ethoxyprecriwelline (84). Biologically, no significant activities were detected for any of these alkaloids in serotonin tranporter, antibacterial, anti-inflammatory and AChE assays [17e, 21a-c].
Three separate studies targeting the alkaloid constituents of South African Amaryllidaceae species were carried out in the year 2000. The first of these by Campbell et al. described from Brunsvigia radulosa the isolation of eight alkaloids, including lycorine (2), crinine (3), crinamine (11), hamayne (15), 1-epideacetylbowdensine (50), anhydrolycorin-6-one (68), sternbergine (72) and 1-O-acetylnorpluviine (73), the last of which was uncovered as a novel compound [22] . During the study, crinamine was converted under strongly acidic conditions to its highly strained 3,11-cyclic ether, apohaemanthamine (34) . In the cytotoxicity assay against BL6 mouse melanoma cells, all of the compounds, with the exception of 1-epideacetylbowdensine (50) and apohaemanthamine (34) (IC 50 s > 100 g/mL), exhibited strong activities with IC 50 s in the range 1.6 to 9.4 g/mL [22] . In relation to antimalarial activity, lycorine (2), as shown previously [18] , was the most active of the compounds isolated, in this case against both chloroquine-sensitive D10 and chloroquine-resistant FAC8 strains of Plasmodium falciparum with IC 50 values of 0.6 g/mL (SI 2.67) and 0.7 g/mL (SI 2.86), respectively [22] . Secondly, work by Koorbanally et al. [23] resulted in the identification of eight known alkaloid structures from Ammocharis coranica, including lycorine (2), acetylcaranine (63), crinamine (11), 1-O-acetyllycorine (62), hippadine (70), 6hydroxypowelline (46) , hamayne (15) and 1-O-acetylnorpluviine (73), in addition to four triterpenoid structures. Finally, Crinum macowanii bulb extracts yielded the novel compound macowine (54) in addition to ten other known alkaloids, including lycorine (2), crinine (3), krepowine (37) , buphanidrine (43) , powelline (45), 1epideacteylbowdensine (50), 4a-dehydroxycrinamibine (51), undulatine (57), crinamidine (58) and cherylline (99) [24] . Macowine (54) together with paucamine salt 55 are unique in that they are the only -crinane representatives isolated during this period in which the 1,3-dioxolane ring, normally attached to the aryl A-ring moiety, has been replaced by 1,2-disubstitution. Interestingly, of the alkaloids isolated, only lycorine was active against the NF54 strain of Plasmodium falciparum (IC 50 0.34 g/mL) when screened against chloroquine and qinghaosu as positive controls [24] . While no antiparasitic activities were recorded for Leishmania donovani and Trypanosoma cruzi, 4adehydroxycrinamibine (51) was noticeably active against Trypanosoma brucei rhodesiense (IC 50 11.07 g/mL) [24] .
The year 2001 saw four pieces of work from the field, inclusive of three Crinums and a single Cyrtanthus species [25] [26] [27] [28] . Of these, Crinum moorei was particularly abundant in alkaloid constitution, affording 13 alkaloids, mostly of the crinane series (Table 1 ) [25] . In the process compound 26, in possession of a unique 4'ethylamino-substituted phenyl group at C-3 on the bulbispermine (25) skeleton, together with the lycorane mooreine (71) were identified as novel compounds [25] . Mooreine is in itself unique as it represents the first member of the lycorine series in possession of C-4a substitution, in this case with a methoxy group, leading to quaternization of this carbon center. Of the 13 compound library, 1-O-acetyllycorine (62) was most prominent for its potent AChE inhibitory activity (IC 50 0.96 M), proving to be even more potent than the Alzheimer's schedule drug galanthamine (1) (IC 50 1.9 M) [21b,c]. Furthermore, 3-epivittatine (22) and cherylline (99) showed marked affinity for the serotonin reuptake transporter protein with IC 50 s of 12.1 and 3.4 M, respectively, as determined by their ability to competitively inhibit [ 3 H]-citalopram binding to the transporter [17e]. A further study of Crinum macowanii [26] , albeit with material sourced from a different location to the previous study described above [24] , yielded five known alkaloids including lycorine (2), crinine (3), hamayne (15) , bulbispermine (25) and cherylline (99). Of these, hamayne and bulbispermine were not isolated in the previous investigation [24] . Following closely on this work, Elgorashi and Van Staden (2001) [27] described the presence of lycorine (2), crinine (3) and hamayne (15) from bulbs of the rare Amaryllid Crinum lugardiae, all three of which were also common to C. macowanii [26] . Finally, a study on Cyrtanthus elatus by Herrera et al. (2001) [28] revealed the presence of the known alkaloids galanthamine (1), haemanthamine (20) and haemanthidine (21), in addition to two novel compounds zephyranthine (74) and 1,2-di-O-acetylzephyranthine (75), which are structurally 2-epidihydro analogues of the corresponding lycorine compounds. Furthermore, the plant was seen to be a significant source of the Alzheimer's drug galanthamine, yielding 200 mg of compound from 1.5 kg of fresh bulbs [28] .
Several other significant chemical and pharmacological discoveries [13a-c,29a-g] evolved out of the isolation of lycorine (2), crinamine (11) and hamayne (15) from Brunsvigia radulosa [22] , as well as haemanthamine (20) from Cyrtanthus elatus [28] . In relation to their cytotoxic abilities, both crinamine and haemanthamine were shown to manifest this activity via the apoptotic pathway, as demonstrated in rat hepatoma (5123tc) cells [29a-c] . As shown in Figure 2 , apoptotic nuclei of these cells treated with Hoechst stain appeared brighter and more fragmented than healthy nuclei, in this case upon treatment with crinamine (11) [29a-c]. Furthermore, respective ED 50 values were established at 12.5 M and 15 M for crinamine (11) and haemanthamine (20) (Figure 3 ) [29a-c]. These results were even more impressive considering the selectivities of crinamine (11) and haemanthamine (20) , both of which were seen to exhibit negligible apoptotic effects in normal human embryonic kidney (293t) cells ( Figure 4) 
In addition, elements of the apoptosis-inducing pharmacophore were uncovered incorporating other semi-synthetic derivatives such as 12, 13, 34, 35 and 36. This aspect of crinane alkaloids will be elaborated later in the review. Apart from this, several aspects of the biologically-active lycorine pharmacophore were revealed [29d-g]. Synthetically, it was found that facile access to C-2 functionalized lycorine analogues was achievable via direct desymmetrization of the 1,2-dihydroxy groups. To this extent, bulky electrophiles such as tert-butyldimethylsilyl (TBS) groups could be introduced regioselectively, in fair yields, to the more reactive C-2 allylic hydroxy group as opposed to the homoallylic C-1 hydroxy group, leading to analogue (64) [29d-g]. Further functionalization at C-1 of this key intermediate with acyl groups then led to 1,2-disubstituted analogues such as 65 and 66, which could be readily resolved via appropriate deprotection strategies to their desired 1-acyl targets {1-O-acetyllycorine (62) and 1-O-benzoyllycorine (67)}. Although none of the synthesized variants exhibited appreciable cytotoxicity in human leukemia (Jurkat) cells, the parent compound lycorine by contrast was potent at this activity and shown to mechanistically initiate these effects via the apoptotic pathway [29d]. On the other hand, silylated analogues 65 and 66 were seen to be the most active AChE inhibitors identified to date within the lycorine series of compounds with Ki values of 0.34 and 0.39 M. Pharmacophorically, the lipophilic silylative effect in the C-2 region of the molecules accompanied by an acyl binding pocket at the enzyme active site to accommodate the C-1 functionalities, as well as the close structural similarity of these molecules to the standard AChE inhibitor galanthamine, with the benefit of significant areas of overlap along their pharmacophores, were suggested as being responsible for this enhanced activity [29e-g]. In addition, all of the silylated derivatives (64-66) were shown to possess potent cytochrome P450 3A4 (CYP3A4) inhibitory activity (Kis of 0.21 to 0.99 M) [13a,c] . This was a significant finding since these mono-oxygenase isoenzymes are involved in the detoxification of a wide variety of xenobiotics such as drugs, biogenic amines from food sources, environmental toxins, and chemical carcinogens, and in the oxidation of steroids, fatty acids, prostaglandins, leukotrienes, and fat-soluble vitamins [13a,c] . For this reason, this discovery may prove critical in guiding the development of future chemotherapeutic drug candidates from the family.
Based on the traditional usage of Brunsvigia radulosa for its psychoactive properties, bulbs of the plant were examined during 2002 for constituents that could exhibit such effects [30] . During the investigation, six alkaloids were isolated and identified as lycorine (2), crinine (3), crinamine (11), hamayne (15), 1-O-acetyllycorine (62) and anhydrolycorinium chloride (69) ( Table 1 ). Furthermore, although they do not provide any pharmacological evidence to support their postulation, the authors suggested that crinamine may be responsible for the psychoactive properties of Brunsvigia radulosa [30] . In terms of chemosystematics, the first four alkaloids were also shown to be present in the plant as previously recorded by Campbell et al. in 2000 from a collection made in the Orange Free State [22] . In addition, this was the first description of chloride 69 from the genus Brunsvigia and only its second time from any South African Amaryllid, the previous occasion being from Amaryllis belladonna [15] . Also in the year 2002, Brine et al. studied Cyrtanthus obliquus, a species indigenous to the Western and Eastern Cape Provinces, as well as parts of KwaZulu-Natal [31] . In the process, three alkaloids of the tazettine group {tazettine (5), obliquine (85) and 3-epimacronine (86)} together with trisphaeridine (7), narcissidine (76) and 11-hydroxygalanthamine (79) were identified by a combination of physical and spectroscopic means [31] . In the structure of obliquine the oxygen of the pyranoid ring-B moiety, typical of tazettine structures [15] , has been replaced by the nitrogen atom. All compounds were screened for cytotoxicity against two mammalian cancer cell lines, namely Chinese Hamster Ovarian (CHO) and human hepatoma (HepG2) cells, but no activities were detected at concentrations up to 100 g/mL [31] . (20), haemanthidine (21), haemanthidine salt (27) and tazettine salt (80). Free forms of the salts were obtained upon saponification with NaOH [32] . Secondly, studies by Elgorashi and Van Staden on Cyrtanthus falcatus led to the identification of four known compounds, namely tazettine (5), maritidine (28) , Omethylmaritidine (29), and papyramine (30) from bulb methanolic extracts [33] . The presence of the last three compounds is of biosystematic relevance as they have never previously been identified in any member of the South African Amaryllidaceae [15] . Thirdly, while no direct phytochemical analyses were carried out, Elgorashi et al. used GC analysis to examine the interspecific variation in alkaloid content of three Crinum species over a two year period [34] , thus being able to distinguish between C. moorei on the one hand and C. bulbispermum and C. macowanii on the other. [35] . Although no alkaloids were isolated, various extracts of these plants were shown to exhibit significant biological activities. Of note was the broad spectrum antibacterial activity of CH 2 Cl 2 bulb/root extracts of C. suaveolens, the anti-inflammatory activity of various CH 2 Cl 2 extracts of all species which inhibited COX-1 and COX-2 by at least 70%, and the mutagenic effects of CH 2 Cl 2 extracts of C. falcatus and C. suaveolens, as shown by the Salmonella/microsome assay strain TA98 [35] . As an extension of this work, Elgorashi et al. then examined Cyrtanthus suaveolens for any phytochemical constituents which might corroborate its potent mutagenic activity [36] . Although no alkaloids were isolated, the common pesticide captan was identified as the component responsible for this effect [36] . Next, by means of preparative HPLC coupled online to a flow assay system, Rhee et al. [37] identified ungeremine (77) as the compound responsible for its AChE inhibitory activity. In this regard, the compound with an IC 50 of 0.35 M was even more potent than galanthamine (IC 50 2.2 M) [37] . The last two investigations for the year 2004 were those of Moodley [38] who examined Brunsvigia natalensis and Crinum stuhlmanii based on their popular usage in Zulu medicinal culture. B. natalensis afforded the novel crinane alkaloids nivanine A (24) and nivanine B (56) in addition to a flavan and a ceramide. Nivanine A is the 11-dehydroxy analogue corresponding to crinamine (11), while nivanine B is the first of the South African -crinanes to possess substitution at C-4, in this case with an -acetoxy group [38] . By contrast, Crinum stuhlmannii yielded eleven alkaloids, five of which (17,31,32,52,53), of the crinane series, were shown to be new (Table 1 ) [38] . Of these, stuhlmanine D (98) and N-methyldelagoenine (32) were significant as the former is the first member of the crinane group to possess a methano bridge (as opposed to the usual ethano bridge) straddling the N-to C-10b positions, while 32 is only the third of all crinane compounds with substitution at C-12, the previous two being delagoensine (18) and delagoenine (19) , which were identified as novel constituents of Crinum delagoense [19] . Of all the compounds from Brunsvigia natalensis and Crinum stuhlmanii, screened for cytotoxicity, only lycorine (2) exhibited activity against melanoma UACC62, renal TK10 and breast MCF7 cells with total growth inhibition (TGI) values of 6.25, 39 and 100 ppm, respectively [38] . Furthermore, none of the compounds exhibited antioxidant activity as determined by the DPPH radical scavenging assay [38] . [39] [40] [41] . First, the known crinane alkaloids buphanidrine (43) and buphanamine (59) from bulbs of Boophone disticha were shown to be the constituents responsible for its traditionally usage for depression and anxiety [17d]. As such, IC 50 values for the two compounds in the serotonin transporter binding assay, with [ 3 H]citalopram as ligand, were 274 M and 1799 M, respectively [17d]. Furthermore, the authors suggested that the benzo-1,3dioxole moiety in buphanidrine (43) [39] . To this extent, H. albiflos gave the known alkaloids homolycorine (4), albomaculine (87) and O-methyllycorenium salt (91), while coccinine (93), montanine (6 and manthidine salt (95) were identified in H. deformis [39] . In turn, H. pauculifolius was shown to contain homolycorine (4), paucamine salt (55), homolycorine salt (88), montanine salt (94) and manthidine salt (95) [39] . The protonated quaternary ammonium salts were released as free bases upon treatment with NaOH [39] . As previously noted [15] , and in line with the findings of this study, montanine compounds appear to be quite ubiquitous to the genus Haemanthus. (20) , lycorine (2), crinamine hydrochloride (33) and tazettine (5) were found [40] . Finally for this period, Nerine filifolia from a commercial source in the Western Cape Province yielded the novel alkaloids N-demethylbelladine (97), 6-methoxybuphanidrine (48) and filifoline (42) , together with four known crinane compounds (38, 39, 47, 57) and belladine (96) [41] . In addition, and unprecedented for the Amaryllidaceae, the plant was seen to produce significant amounts of phenol. Compounds such as belladine (96) and N-demethylbelladine (97), in contrast to the universal precursor {norbelladine (9)} for this family of alkaloids, are at a biogenetic dead-end as they cannot be further oxidized (by phenolic coupling) into the various possible structures of the Amaryllidaceae due to their being fully O-methylated [41] . Consequently, they occur merely as organic bases of the plant [41] . Further to this, filifoline (42) was unreactive towards rat myoblast L6 cells and exhibited no activity in the in vitro screen against four different protozoan parasites, Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani and Plasmodium falciparum [41] . Structurally, filifoline (42) is unique in possessing a nicotinate ester at C-11endo and represents the only member of the global crinane series with such a substitution. A further discovery of this study related to the unusual circular dichroism (CD) parameters measured for filifoline [41] . A typical CD curve for a -crinane (such as 11-O-acetylambelline (39) , isolated during the study of Nerine filifolia) exhibits a maximum around 250 nm and a minimum in the region of 286 nm ( Figure 5 ). In the case of filifoline (42) this was seen to be reversed (maximum at 290 nm and minimum at 246 nm) and characteristic of an -crinane compound ( Figure 6 ). However, the possibility of filifoline being an -crinane was ruled out since base hydrolysis of the compound gave ambelline (a -crinane). Hence, it was postulated that bulky, electron-rich substituents (such as the nicotinate ester) at C-11endo were responsible for this anomalous effect in reversing the molecular ellipticity of crinane compounds, as shown through CD. It was suggested that compounds such as filifoline are mechanistically able to achieve this by overriding the influence of the dominant methylenedioxyphenyl (MDP) chromophore typical of crinane alkaloids. Further evidence for this came from the semisynthetic preparation of 11-O-benzoylambelline (41) and 11-Omethanesulphonylambelline (40) from ambelline (38) , whose CD curves were in accordance with the postulate [41] (Figures 7 and 8) .
The period 2006-2008 saw no alkaloids being reported from South African Amaryllidaceae sources. However, during this time, Elgorashi et al. demonstrated the marked affinity of 3-epivittatine (22) and cherylline (99), previously isolated from Crinum moorei [25] , for the serotonin reuptake transporter protein as determined by their ability to competitively inhibit [ 3 H]-citalopram binding to the transporter [17e]. Furthermore, Elgorashi et al. described the presence of isoeugenitol and its 5-O-glucoside together with 9Zoctadec-9-enamide in bulbs of Gethyllis ciliaris [42] . While isoeugenitol exhibited significant activity against COX-1, its activity against COX-2 was marginal, indicating its effect as a selective anti-inflammatory agent [42] . Lastly, work by Kamatou et al. on the fruits of Gethyllis afra and G. ciliaris indicated the presence of 72 known volatile compounds, mostly esters, as determined by GC-MS after solid phase micro-extraction [43] . The following year Van Rijn et al. investigated Nerine bowdenii as a potential source of AChE inhibitory compounds [44] , in the process identifying five -crinane alkaloids, ambelline (38) , buphanisine (44) , undulatine (57), 11-O-acetylambelline (39) and filifoline (42) . Of these, only undulatine was notably active against the AChE enzyme, with an IC 50 of 37 M. The presence of filifoline is systematically significant as the compound was previously identified only in Nerine filifolia [41] . Ending with this period, the 'fire lily' Cyrtanthus contractus was examined for alkaloid constituents that might interact with the AChE enzyme [45] . In the event, a single alkaloid {narciprimine (78)} was isolated from bulbs of the plant and shown to be moderately active (IC 50 of 78.9 M) [45] , thus shedding light on the structural features of the AChE inhibitory pharmacophore attending the lycorine series of compounds [29g]. In addition, this work represented the first isolation of narciprimine from an African Amaryllid [45] . It was previously detected in Zephyranthes, Narcissus and Lycoris, genera endemic to the Americas, Europe and Asia, respectively [45] . However, more significant than these attributes was the screening of narciprimine (78) for cytotoxic effects [46] , due to its close structural proximity to the phenanthridones, such as pancratistatin (10) of the lycorine series of alkaloids, which are known for their potent and selective anticancer properties [10, 11, 12, 14] . To this extent, narciprimine was screened against a mini-panel of cancer cells comprising acute lymphoblastic leukemia (CEM), chronic myelogenous leukemia (K562), breast adenocarcinoma (MCF7), malignant melanoma (G-361) and cervical adenocarcinoma (HeLa), as well as the normal human fibroblast (BJ) cell line [46] . It demonstrated moderate activity against CEM cells (IC 50 13.3 M) and weak activity against all other cancer cells (IC 50 s > 50 M) [46] . However, the compound was non-selectively active as it also targeted normal BJ cells (IC 50 7.9 M) [46] . In terms of the phenanthridone pharmacophore, the low cytotoxic activity observed for the C-ring unsaturated phenanthridone narciprimine (78) is not unanticipated given the planar nature of its structure and the fact that the most potent variants of the series, such as pancratistatin (10), have stereodefined polyhydroxy C-ring functionalities [10, 11, 12, 14] .
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Intriguingly, three of the four references to the southern African Amaryllidaceae in 2012 were in relation to the genus Boophone, one of eleven genera of the tribe Amaryllideae, comprising the known species B. disticha and B. haemanthoides. First, Cheesman et al. [47] identified buphanidrine (43) and distichamine (60) from bulbs of B. disticha as antimicrobial agents which might corroborate its use in ethnic medicine for wounds and infections [15] . As such, buphanidrine (43) and distichamine (60) were uncovered as novel, broad spectrum, moderately-active antibacterial agents with the best MIC value detected at 0.063 mg/mL for Staphylococcus aureus, Escherichia coli and Klebsiella pneumoniae [47] . MIC values for Bacillus subtilis were two fold less than that observed for the other three bacteria, suggesting that the extract and pure compounds were selective in their interaction with the bacterial pathogens [47] . Secondly, B. disticha was again targeted for phytochemical investigation by Adewusi et al. leading to the isolation of the -crinane 6-hydroxycrinamine (14) [48] , which was unusual as all crinanes isolated previously from the plant were of the -series [17d-f, 47]. Although 6-hydroxycrinamine exhibited low interaction with the AChE enzyme (IC 50 445 M), its cytotoxic effects against human neuroblastoma (SH-SY5Y) was notable at 54.5 and 61.7 M, as determined by the MTT and neutral red assays, respectively [48] , in agreement with the activity previously shown for the same compound isolated from Crinum delagoense [19] . Thirdly, phytochemical analysis of Boophone haemanthoides which, as mentioned above, is one of the two known species in the genus Boophone. In this instance, B. haemanthoides was shown to contain four known alkaloids, namely crinine (3), buphanisine (44) , buphanidrine (43) and distichamine (60), all of the -crinane series [49] . Furthermore, from this finding, distichamine (60), a structurally unique compound in possessing both vinylic methoxyl as well as ,-unsaturated ketone C-ring functionalities, was identified as a distinctive chemotaxonomic marker for Boophone, having never been identified outside of this genus [49] . Finally, the known alkaloid bulbispermine (25) isolated from Crinum bulbispermum, was recently shown to exhibit promising cytotoxic activity against both apopotosis-sensitive and apoptosis-resistant cell lines with GI 50 s ranging from 8-38 M [50] . In relation to the cytotoxicity of distichamine (60), the compound was seen to possess good activities against all the cell lines described for narciprimine (78) above [46, 51] , with IC 50 s ranging from 14.7 M (G-361 cells) to 2.2 M (HeLa cells), as shown by the Calcein AM assay. Furthermore, the compound was seen to manifest this activity via the apoptotic pathway, as demonstrated in CEM cells [46, 51] , and subsequently shown to be amongst the most potent naturallyoccurring crinane compounds [51] . Mechanistic studies as invoked through flow cytometry were used to quantify the distribution of CEM cells across the different phases of the cell cycle, and to determine the sub-G 1 fraction as a measure of the proportion of apoptotic cells [46, 51] . The analysis showed that treatment with (Figure 9) [46, 51] . In addition, the proportion of cells with sub-G 1 amounts of DNA (apoptotic cells) increased (up to 23.7 %) following a 24 h treatment with 60, relative to that observed in untreated cells, indicating that the compound was clearly capable of cell cycle disturbance and apoptosis induction in CEM cells [46, 51] . Furthermore, distichamine induced a 12.5-fold increase in the activity of caspase-3/7 after 24 h at the highest concentration (20 M) compared with untreated controls (Figure 10 ). In addition, Western blot analysis was used to detect changes in expression of apoptosis-related proteins in CEM leukemia cells after treatment with distichamine. As shown in Figure 11 , treatment with 60 (at 10 and 20 µM) induced cleavage of PARP (89 kDa fragment) after 24 h, which also corresponded with decreased levels of procaspase-3. As described above, increased caspase-3 activity was observed over the same treatment period and dosage ( Figure 10) . Expression of the tumor suppressor protein p53 was discernible in the CEM cell line control, and 60 caused its enhanced expression after 24 h, notably at 10 and 20 µM ( Figure  11 ). No change in the expression of the antiapoptotic protein Bcl-2 was observed, but at 20 µM, a decreased level of the antiapoptotic protein Mcl-1 was detected, indicating the onset of apoptosis. Western blot analysis demonstrated the dose-dependent decrease of procaspase-3 and cleavage of PARP after 24 h treatment with distichamine (60) in CEM leukemia cells (Figure 11) , indicating that the compound induces caspase-3 activated apoptosis [46, 51] .
Given the unique C-ring structural formulation for distichamine, involving shift of the double bond to C-2/C-3 with concomitant vinylization of the C-3 methoxy group and oxidation at C-1, these findings point at further attendant structural features of the crinane apoptosis-inducing pharmacophore. It now appears that a sp 2hybridised C-3 center is tolerated at the active site, since most other cytotoxic crinane alkaloids possess a C-1/C-2 double bond.
Through these findings [46, 51] and those described above [29a-c] , essential features of the apoptosis-inducing pharmacophore innate to crinane alkaloids have come to light. These were shown to include: 1) an intact phenanthridine nucleus is essential since truncated analogues were markedly less active; 2) presence of the A-ring methylenedioxyphenyl moiety since structures incorporating other substituents were seen to be less active; 3) B-ring modification effects such as quaternization of the nitrogen atom were shown to be deleterious; 4) small substituents with hydrogen bond donor/acceptor capability at C-11 ( to the nitrogen atom) with either exo-or endo-disposition were ameliorative (as in crinamine (11) and bulbispermine (25), respectively), but less so for substitutions  to the nitrogen atom at C-6 {6-hydroxycrinamine (14) or C-12 (delagoensine (18)}; 5) stereochemistry at C-3 may not be significant given the relative configurations of the methoxyl group in crinamine (11) and haemanthamine (20) , as well as its planar geometry in distichamine (60); 6) additional oxygenation of ring-A, reminiscent of the potent anticancer phenanthridone pancratistatin (10), is viewed as beneficial to the pharmacophore, as shown for distichamine (60); and 7) although active compounds were found across both and -members of the series, the geometry of the 5,10b-ethano bridge appears to play a significant role given the consistent potency of the former series across most of the cell lines screened. In addition, mechanistic studies have recently uncovered the apoptotic mode of death as responsible for the cytotoxicity of several crinane compounds [29a-c, 46,51] . These distinctive features should prove useful in guiding the development of a clinical drug target.
In summary, a comprehensive view of the South African Amaryllidaceae has emerged for the period 1998-2012 taking into account developments in the areas of ethnobotany, phytochemistry and pharmacology. This study follows on a previous review of the family covering all years up to 1997. For the fifteen-year period of the present review, significant progress has been made in the three areas outlined as the focus of the study. First, there have been sustained efforts to ensure that plant selection is based chiefly on documented traditional usage. This should serve to not only guide efforts in drug discovery, but also to ensure that indigenous communities benefit from the assimilation of such indigenous knowledge. Given the widespread usage of the Amaryllidaceae in ethnic medicine, in several instances with a net negative impact on wild Amaryllid populations, it is imperative that strategies be formulated to regulate the sustainable usage of these plants. To this extent, the South African government should be commended for its continued efforts to integrate traditional medicine into the mainstream healthcare sector. In addition, advances in the biotechnological arena have facilitated the availability of propagated species at traditional herbal markets to bolster stocks under threat from unsustainable and unscrupulous practices. Secondly, many novel alkaloids have been identified from the 26 different species examined, thus adding to the sizeable library of compounds known from plants of this region. In total, 83 alkaloids were identified, which is a significant number as the previous review accounted for the presence of 110 compounds in 62 species. This complement represents roughly a third of the Amaryllid species known from this region, and thus points at the requirement for concerted efforts to fully uncover the phytochemical and pharmacological potential of this plant family. Furthermore, many of the species previously examined were based on qualitative assaying techniques and could thus be re-visited for full analyses. In addition, phytochemical investigation should be led by bioassayguided fractionation and isolation strategies. Thirdly, in contrast to the previous review, there has been an exponential growth in the pharmacological interest of these chemical entities, some of which could be traced directly to traditional usage of the plants. In this regard, there has been renewed interest in the medicinal potential of the family, especially in the areas of cancer and Alzheimer's chemotherapy. During the review period, two significant milestones were accomplished; firstly, the commercialization of galanthamine as an Alzheimer's prescription drug; and secondly, the entry of the potential cancer drug pancratistatin into clinical trials. These two accomplishments should thus spur on investigations aimed at targets with improved activities and selectivities. With this as a backdrop and given the natural abundance of the Amaryllidaceae in the southern African region, the possibility of new pharmacological discoveries being made remains a genuine possibility.
